Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia.

[1]  P. Catalano,et al.  Management of obesity in pregnancy , 2022, The Australian & New Zealand journal of obstetrics & gynaecology.

[2]  S. Hauguel-de Mouzon,et al.  Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? , 2011, American journal of obstetrics and gynecology.

[3]  R. Gibbs,et al.  The Interrelationship of Complement-Activation Fragments and Angiogenesis-related Factors in Early Pregnancy and Their Association With Preeclampsia , 2011 .

[4]  L. Poston,et al.  Obesity in Pregnancy: Implications for the Mother and Lifelong Health of the Child. A Consensus Statement , 2011, Pediatric Research.

[5]  R. Gibbs,et al.  Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes , 2011, Obstetrics and gynecology.

[6]  A. Siega-Riz,et al.  The Impact of Exposure Misclassification on Associations Between Prepregnancy BMI and Adverse Pregnancy Outcomes , 2010, Obesity.

[7]  J. Salmon,et al.  Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. , 2010, Placenta.

[8]  R. Romero,et al.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  Z. Prohászka,et al.  Activation of the complement system in normal pregnancy and preeclampsia. , 2010, Molecular immunology.

[10]  S. Blackwell,et al.  Autoantibody-Mediated Angiotensin Receptor Activation Contributes to Preeclampsia Through Tumor Necrosis Factor-&agr; Signaling , 2010, Hypertension.

[11]  V. Holers,et al.  The interrelationship of complement‐activation fragments and angiogenesis‐related factors in early pregnancy and their association with pre‐eclampsia , 2010, BJOG : an international journal of obstetrics and gynaecology.

[12]  J. Moreno-Navarrete,et al.  Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance , 2009, Diabetes.

[13]  T. Byers,et al.  Complement Activation Fragment Bb in Early Pregnancy and Spontaneous Preterm Birth , 2009 .

[14]  S. Hauguel-de Mouzon,et al.  Fetuses of Obese Mothers Develop Insulin Resistance in Utero , 2009, Diabetes Care.

[15]  P. Catalano,et al.  Pregnancy and obesity. , 2009, Obstetrics and gynecology clinics of North America.

[16]  Lelia Duley,et al.  The global impact of pre-eclampsia and eclampsia. , 2009, Seminars in perinatology.

[17]  T. Byers,et al.  Alternative Complement Pathway Activation Fragment Bb in Early Pregnancy as a Predictor of Preeclampsia , 2009 .

[18]  A. Vahratian.  Prevalence of Overweight and Obesity Among Women of Childbearing Age: Results from the 2002 National Survey of Family Growth , 2009, Maternal and Child Health Journal.

[19]  J. Luckett,et al.  Dual role of complement in adipose tissue. , 2009, Molecular immunology.

[20]  A. Benachi,et al.  Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. , 2008, Blood.

[21]  J. Atkinson,et al.  Advances in understanding of pathogenesis of aHUS and HELLP , 2008, British journal of haematology.

[22]  Y. Sadovsky,et al.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. , 2008, Placenta.

[23]  T. Byers,et al.  Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. , 2008, American journal of obstetrics and gynecology.

[24]  A. Włoch,et al.  Acylation stimulating protein is associated with pregnancy weight gain. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[25]  R. Romero,et al.  ORIGINAL ARTICLE: A Role for Mannose‐Binding Lectin, a Component of the Innate Immune System in Pre‐Eclampsia , 2008, American journal of reproductive immunology.

[26]  V. M. Holers,et al.  The spectrum of complement alternative pathway‐mediated diseases , 2008, Immunological reviews.

[27]  T. Byers,et al.  Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. , 2008, American journal of obstetrics and gynecology.

[28]  S. Hauguel-de Mouzon,et al.  Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. , 2008, Placenta.

[29]  J. Atkinson,et al.  Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. , 2007, Blood.

[30]  A. Hernández-Mijares,et al.  Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors , 2007, International Journal of Obesity.

[31]  D. Bernlohr,et al.  Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance. , 2007, American journal of physiology. Endocrinology and metabolism.

[32]  K. Clément,et al.  Review article: Is obesity an inflammatory illness? Role of low‐grade inflammation and macrophage infiltration in human white adipose tissue , 2006 .

[33]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[34]  R. Romero,et al.  Anaphylatoxins in preterm and term labor , 2005 .

[35]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[36]  J. Thurman,et al.  The alternative pathway of complement in disease: opportunities for therapeutic targeting. , 2004, Molecular immunology.

[37]  L. Lönn,et al.  High expression of complement components in omental adipose tissue in obese men. , 2003, Obesity research.

[38]  I. Sargent,et al.  Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review. , 2003, Placenta.

[39]  K. Cianflone,et al.  Critical review of acylation-stimulating protein physiology in humans and rodents. , 2003, Biochimica et biophysica acta.

[40]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[41]  Vu,et al.  Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations , 1999, European journal of clinical investigation.

[42]  J. Canterino,et al.  Amniotic Fluid Complement C3 as a Marker of Intra‐amniotic Infection , 1998, Obstetrics and gynecology.

[43]  P. Anderson.  Clinical Immunology: Principles and Practice , 1996 .

[44]  C. Janeway.  Immunobiology: The Immune System in Health and Disease , 1996 .

[45]  A. Bengtsson,et al.  Complement, neutrophil and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes and low platelet count , 1992, Obstetrics and Gynecology.

[46]  B. Spiegelman,et al.  Adipsin and an endogenous pathway of complement from adipose cells. , 1992, The Journal of biological chemistry.

[47]  B. Spiegelman,et al.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. , 1992, The Journal of biological chemistry.

[48]  R. Eckel,et al.  Levels of acylation stimulating protein in obese women before and after moderate weight loss. , 1991, International journal of obesity.

[49]  B. Spiegelman,et al.  Adipsin and complement factor D activity: an immune-related defect in obesity , 1989, Science.

[50]  B. Spiegelman,et al.  Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. , 1987, Science.

[51]  C. Williams.  Weight in Relation to Pregnancy Toxaemia , 1957, British medical journal.

[52]  L. Dublin,et al.  Obesity and its relation to health and disease. , 1951, Journal of the American Medical Association.

[53]  Heidi M. Blanck,et al.  Vital signs: state-specific obesity prevalence among adults --- United States, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[54]  K. Clément,et al.  L’obésité est-elle une maladie inflammatoire ? , 2006 .